Publications by authors named "Mette D Hazenberg"

Claim this Profile
T
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Cilia R Pothast, Quincy Hofsink, Sabine Haggenburg, Romy C Dijkland, Marian Van de Meent, Mette D Hazenberg

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyurea.
Sabine Haggenburg, Cilia R Pothast, Quincy Hofsink, Nienke J E Haverkate, Michel S Bhoekhan, Mette D Hazenberg

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the Integration of 'Basic/Fundamental' and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress.
Donal P McLornan, Mette D Hazenberg, Fabio Ciceri, Tobias Alexander, Emanuele Angelucci

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Effectiveness in Patients with Hematologic Malignancies: a Nationwide Cohort Study.
Quincy Hofsink, Birgit I Lissenberg-Witte, Sabine Haggenburg, Abraham Goorhuis, Mette D Hazenberg

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT.
Nicole Santoro, Christoph Schmid, Moniek de Witte, Mieke W H Roeven, Victoria Potter, Mette D Hazenberg

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urgent need: evidence-based use of donor lymphocyte infusions - Authors' reply.
Simona Pagliuca, Christoph Schmid, Nicole Santoro, Federico Simonetta, Giorgia Battipaglia, Mette D Hazenberg

Lancet Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.
Man Wai Tang, Deborah Van der Tuin, Mesire Aydin, Jarom Heijmans, Arjan A Van de Loosdrecht, Mette D Hazenberg

Eur J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.
Jakob R Passweg, Helen Baldomero, Marina Atlija, Iliana Kleovoulou, Aleksandra Witaszek, Mette D Hazenberg

Bone Marrow Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Effects of Heme Oxygenase-1 Expression in Patients and Mice with Acute Graft-Versus-Host Disease?
Myrddin W Verheij, Ingrid Bulder, Mark Hoogenboezem, Ji-Ying Song, Mette D Hazenberg

Stem Cells Dev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT.
Jakob R Passweg, Helen Baldomero, Tobias Alexander, Emanuele Angelucci, Dina Averbuch, Mette D Hazenberg

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Yoshiko Atsuta, Helen Baldomero, Daniel Neumann, Anna Sureda, Jakob D DeVos, Mette D Hazenberg

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Magda Vergouwe, Jason J Biemond, Karlijn van der Straten, Lisa van Pul, Gius Kerster, Mette D Hazenberg

J Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study.
Elisabeth Dovern, Mesire Aydin, Mette D Hazenberg, Man Wai Tang, Elisabeth M Suijk

Am J Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT.
Jakob R Passweg, Helen Baldomero, Fabio Ciceri, Rafael de la Cámara, Bertram Glass, Mette D Hazenberg

Bone Marrow Transplant· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.
Simona Pagliuca, Christoph Schmid, Nicole Santoro, Federico Simonetta, Giorgia Battipaglia, Mette D Hazenberg

Lancet Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Source of hematopoietic progenitor cells determines their capacity to generate innate lymphoid cells ex vivo.
Said Z Omar, Vera van Hoeven, Nienke J E Haverkate, Jolien M R Van der Meer, Carlijn Voermans, Mette D Hazenberg

Cytotherapy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of human ILC3 from allogeneic and autologous CD34 hematopoietic progenitors toward adoptive transfer.
Jolien M R Van der Meer, Ingrid Bulder, Carlijn Kuijk, Marion Kleijer, Myrddin W Verheij, Mette D Hazenberg

Cytotherapy· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Olaf Penack, Monia Marchetti, Mahmoud Aljurf, Mutlu Arat, Francesca Bonifazi, Mette D Hazenberg

Lancet Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant neutrophil degranulation in hospitalized patients with COVID-19 partially remains for 6 months.
Florianne M J Hafkamp, Esther W M Taanman-Kueter, Toni M M van Capel, Elke Wynberg, Hugo D G van Willigen, Mette D Hazenberg

Eur J Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.
Aniko Sijs-Szabo, Avinash G Dinmohamed, Jurjen Versluis, Bronno van der Holt, Mar Bellido, Mette D Hazenberg

Transplantation· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning.
Mesire Aydin, David C de Leeuw, Caroline E Rutten, Otto J Visser, Man Wai Tang, Mette D Hazenberg

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Quincy Hofsink, Sabine Haggenburg, Birgit I Lissenberg-Witte, Annoek E C Broers, Jaap A van Doesum, Mette D Hazenberg

EClinicalMedicine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome in allogeneic HCT survivors: The insults are gone but the damage lingers.
Yannouck van Lier, Mette D Hazenberg

Br J Haematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
Yannouck F van Lier, Jaël Vos, Bianca Blom, Mette D Hazenberg

Gut Microbes· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies.
Sabine Haggenburg, Quincy Hofsink, Caroline E Rutten, Inger S Nijhof, Mette D Hazenberg

Semin Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis